Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131340) titled 'Clinical study to evaluate the efficacy and safety of XW003 injection in OSA obese patients receiving PAP treatment' on Sept. 1.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Obstructive sleep apnea
Intervention:
XW003 injection group:XW003 injection
Recruitment Status: Recruiting
Phase: 3
Date of First Enrollment: 2026-02-11
Target Sample Size: XW003 injection group:70;Placebo group:70;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=310212
Di...